Bacterial Profile and Antimicrobial Susceptibility of Isolates Recovered from Lower Respiratory Tract Infection for Patients in Rizgary Hospital, Erbil

  • Mahmoud A. Chawsheen Department of General Sciences, Faculty of Education, Soran University, Erbil, Kurdistan Region – F.R. Iraq https://orcid.org/0000-0003-2277-1984
  • Ahmed A. Al-Naqshbandi Department of Laboratory, Rizgary Teaching Hospital, Erbil, Kurdistan Region – F.R. Iraq
  • Haval H. Abdulqader Nanakali Hospital for Blood diseases and Cancer, Erbil, Kurdistan Region – F.R. Iraq
DOI: https://doi.org/10.14500/aro.10724
Keywords: Acinetobacter baumannii, Ampicillin, Lower respiratory tract infection, Multidrug resistance, Streptococcus parasanguinis

Abstract

Recognition of etiologies of lower respiratory tract infection (LRTI) may help in delivering effective treatment options and circumvent emergence of antibiotic resistance. This study was carried out to uncover bacterial profile and antibiotic sensitivity patterns among 310 LRTI patients attended Rizagary Hospital between January 2014 to December 2016. Standard laboratory techniques were applied in collecting, processing, and culturing sputum and bronchial wash specimens. VITEK® 2 compact systems were used to identify bacteria and their antibiotic sensitivity patterns. Results showed that Streptococcus parasanguinis and Acinetobacter baumannii were the most abundant gram-positive and gram-negative bacteria (GPB & GNB), respectively, isolated from sputum specimens. From bronchial wash specimens, only GNB were detected and Serratia marcescens was the most abundant one. Antibiotic sensitivity tests revealed that Streptococcus parasanguinis was the most resistant GPB and Acinetobacter baumannii was the most resistant GNB. Sputum recovered GPB were highly resistant to Ampicillin, Erythromycin, Levofloxacin, Trimethoprim/Sulfamethoxazole, and Tetracycline. Bronchial wash recovered GNB were highly resistant to Ampicillin, Minocycline, Pefloxacin, Piperacillin, and Ticarcillin. In conclusion, LRTIs are mainly associated with GNB rather than GPB. The recovered Streptococcus parasanguinis and Acinetobacter baumannii were found to be multidrug-resistant pathogens. Ampicillin was ineffective against any of recovered pathogenic bacteria.

Downloads

Download data is not yet available.

Author Biographies

Mahmoud A. Chawsheen, Department of General Sciences, Faculty of Education, Soran University, Erbil, Kurdistan Region – F.R. Iraq

Mahmoud A. Chawsheen is Assistant Prof. at the Department of General Sciences, Faculty of Education, Soran University. He got the B.Sc. degree in Biological Sciences, the M.Sc. degree in Cell Biology, and the Ph.D. degree Cell Biology as well. His research interests are in Cancer, Multi-drug Resistance, and Cell Signaling. Dr. Mahmoud is a member of the European Association for Cancer Research and The Royal Microscopical Society.

Ahmed A. Al-Naqshbandi, Department of Laboratory, Rizgary Teaching Hospital, Erbil, Kurdistan Region – F.R. Iraq

Ahmed A. Abdulsalam, is a Microbiology Specialist at the Department of Laboratory (Microbiology Unit), Rizgary Teaching Hospital, Director of Health - Erbil. He got the B.Sc. degree in Biology (Microbiology), the M.Sc. degree in Microbiology (Immunology) and he is currently a Ph.D. student at Dept. of Biology, College of Education, Salahaddin University. His research interests are in Immunology, Bacteriology and Molecular Biology. Mr. Ahmed is a member of the Kurdistan Biology Syndicate.

Haval H. Abdulqader, Nanakali Hospital for Blood diseases and Cancer, Erbil, Kurdistan Region – F.R. Iraq

Haval H. Abdulqader is a Pathology Specialist physician at the Department of Laboratory (Microbiology Unit), Nanakali Hospital, Director of Health - Erbil. He got the M.B.Ch.B degree in Medicine and General Surgery, and the F.K.B.M.S degree in Pathology – Clinical Microbiology. His research interests are in Immunology, Bacteriology and Molecular Biology. Dr. Haval is a member of Kurdistan Doctors Syndicate and Kurdistan Society of Pathology.

References

Ali, I. and Butt, M., 2017. Antibiotic susceptibility pattern of bacterial isolates from patients of respiratory tract infection at 43 centers in Punjab, Pakistan. Clinical and Experimental Pharmacology, 7, p.2.

Al-Naqshbandi, A.A., Chawsheen, M.A. and Abdulqader, H.H., 2019. Prevalence and antimicrobial susceptibility of bacterial pathogens isolated from urine specimens received in Rizgary hospital Erbil. Journal of Infection and Public Health, 12, pp.330-336.

Bali, N., Kakru, D., Bashir, H., Lone, S., Farhana, A. and Koul, P., 2016. Lower respiratory tract infections in intensive care units. A four year study from North India. British Journal of Medicine and Medical Research, 11, pp.1-9.

Barac, A., Ong, D.S.Y., Jovancevic, L., Peric, A., Surda, P., Spiric, V.T. and. Rubino, S., 2018. Fungi-induced upper and lower respiratory tract allergic diseases: One entity. Frontiers in Microbiology, 9, p.583.

Baturin, V.A., Shchetinin, E.V. and Malykhin, F.T., 2015. Regional specifics of microbial landscape in outpatients with lower respiratory tract infections. The International Journal of Risk and Safety in Medicine, 27 Suppl 1, pp.S61-2.

Brook, I., 1997. Anaerobic lower respiratory tract infections in children. Clinical Pulmonary Medicine, 4, pp.1-7.

Brookes-Howell, L., Hood, K., Cooper, L., Little, P., Verheij, T., Coenen, S., Godycki-Cwirko, M., Melbye, H., Borras-Santos, A., Worby, P., Jakobsen, K., Goossens, H. and Butler, C.C., 2012. Understanding variation in primary medical care: A nine-country qualitative study of clinicians’ accounts of the non-clinical factors that shape antibiotic prescribing decisions for lower respiratory tract infection. BMJ Open, 2, p.e000796.

Budayanti, N.S., Suryawan, K., Iswari, I.S. and Sukrama, D.M., 2019. The quality of sputum specimens as a predictor of isolated bacteria from patients with lower respiratory tract infections at a tertiary referral hospital, Denpasar, Bali-Indonesia. Frontiers in Medicine, 6, p.64.

Christiansen, K.,1996. Treatment of common lower respiratory tract infections. Australian Prescriber, 16, pp.48-51.

Claeys, K.C., Zasowski, E.J., Trinh, T.D., Lagnf, A.M., Davis, S.L. and Rybak, M.J., 2017. Antimicrobial stewardship opportunities in critically Ill patients with gram-negative lower respiratory tract infections: A multicenter cross-sectional analysis. Infectious Diseases and Therapy, 7, pp.135-146.

Ehlken, B., Ihorst, G., Lippert, B., Rohwedder, A., Petersen, G., Schumacher, M. and Forster, J., 2005. Economic impact of community-acquired and nosocomial lower respiratory tract infections in young children in Germany. European Journal of Pediatrics, 164, pp.607-615.

Fatima, A., Naqvi, S.B., Khaliq, S.A., Perveen, S. and Jabeen, S., 2012. Antimicrobial susceptibility pattern of clinical isolates of Pseudomonas aeruginosa isolated from patients of lower respiratory tract infections. Springerplus, 1, p.70.

Feldman, C. and Richards, G., 2018. Appropriate antibiotic management of bacterial lower respiratory tract infections. F1000Res, 7, p1121.

Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., Cheng, Z., Yu, T., Xia, J., Wei, Y., Wu, W., Xie, X., Yin, W., Li, H., Liu, M., Xiao, Y., Gao, H., Guo, L., Xie, J., Wang, G., Jiang, R., Gao, Z., Jin, Q., Wang, J. and Cao, B., 2020. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet, 395, pp.497-506.

Karlowsky, J.A., Lob, S.H., Kazmierczak, K.M., Young, K., Motyl, M.R. and Sahm, D.F., 2020. In-vitro activity of imipenem/relebactam and key β-lactam agents against gram-negative bacilli isolated from lower respiratory tract infection samples of intensive care unit patients-SMART Surveillance United States 2015-2017. International Journal of Antimicrobial Agents, 55, p.105841.

Kasper, D.L., Braunwald, E., Hauser, S., Longo, D., Jameson, J.L. and Fauci, A.S., 2006. Harrison’s Principles of Internal Medicine. McGraw-Hill Education, New York.

Kedzia, A., Kwapisz, E. and Wierzbowska, M., 2003. Incidence of anaerobic bacteria in respiratory tract infections. Pneumonologia Alergol Pol, 71, pp.68-73.

Khan, S., Priti, S. and Ankit, S., 2015. Bacteria etiological agents causing lower respiratory tract infections and their resistance patterns. Iranian Biomedical Journal, 19, pp.240-246.

Kohlenberg, A., Schwab, F., Geffers, C., Behnke, M., Rüden, H. and Gastmeier, P., 2008. Time-trends for Gram-negative and multidrug-resistant Gram-positive bacteria associated with nosocomial infections in German intensive care units between 2000 and 2005. Clinical Microbiology and Infection, 14, pp.93-96.

Kumar, S., 2016. Essentials of Microbiology. Jaypee Group, Noida. Langelier, C., Kalantar, K.L., Moazed, F., Wilson, M.R., Crawford, E.D., Deiss, T., Belzer, A., Bolourchi, S., Caldera, S., Fung, M., Jauregui, A., Malcolm, K., Lyden, A., Khan, L., Vessel, K., Quan, J., Zinter, M., Chiu, C.Y., Chow, E.D., Wilson, J., Miller, S., Matthay, M.A., Pollard, K.S., Christenson, S., Calfee, C.S. and Derisi, J.L., 2018. Integrating host response and unbiased microbe detection for lower respiratory tract infection diagnosis in critically ill adults. Proceedings of the National Academy of Sciences, 115, pp.E12353-E12362.

Madhi, S.A. and Klugman, K.P., 2006. Acute respiratory infections. In: Jamison, D.T., Feachem, R.G., Makgoba, M.W., Bos, E.R., Baingana, F.K., Hofman, K.J. and Rogo, K.O. (eds.) Disease and Mortality in Sub-Saharan

Africa. The International Bank for Reconstruction and Development, The World Bank, Washington, DC.

Mahashur, A., 2018. Management of lower respiratory tract infection in outpatient settings: Focus on clarithromycin. Lung India: Official Organ of Indian Chest Society, 35, pp.143-149.

Mahon, C.R., Lehman, D.C. and Manuselis, G., 2014. Textbook of Diagnostic Microbiology-E-Book. Elsevier Health Sciences, Amsterdam, Netherlands.

Pavia, A.T., 2011. Viral infections of the lower respiratory tract: Old viruses, new viruses, and the role of diagnosis. Clinical Infectious Diseases, 52, pp.S284-S289.

Prat, C. and Lacoma, A., 2016. Bacteria in the respiratory tract how to treat? Or do not treat? International Journal of Infectious Diseases, 51, pp.113-122.

Ren, L., Gonzalez, R., Wang, Z., Xiang, Z., Wang, Y., Zhou, H., Li, J., Xiao, Y., Yang, Q., Zhang, J., Chen, L., Wang, W., Li, Y., Li, T., Meng, X., Zhang, Y., Vernet, G., Paranhos-Baccalà, G., Chen, J., Jin, Q. and Wang, J., 2009. Prevalence

of human respiratory viruses in adults with acute respiratory tract infections in Beijing, 2005-2007. Clinical Microbiology and Infection, 15, pp.1146-1153.

Shiley, K.T., Lautenbach, E. and Lee, I., 2015. The use of antimicrobial agents after diagnosis of viral respiratory tract infections in hospitalized adults: Antibiotics or anxiolytics? Infection Control and Hospital Epidemiology, 31, pp.1177-1183.

Sinha, A., Kim, S., Ginsberg, G., Franklin, H., Kohberger, R., Strutton, D., Madhi, S.A., Griffiths, U.K. and Klugman, K.P., 2013. Economic burden of acute lower respiratory tract infection in South African children. Paediatrics and International Child Health, 32, pp.65-73.

Tchatchouang, S., Nzouankeu, A., Kenmoe, S., Ngando, L., Penlap, V., Fonkoua, M.C., Pefura-Yone, E.W. and Njouom, R., 2019. Bacterial aetiologies of lower respiratory tract infections among adults in Yaoundé, Cameroon. BioMed Research International, 2019, pp.1-7.

Troeger, C.E., Blacker, B.F., Khalil, I.A., Zimsen, S.R.M., Albertson, S.B., Abate, D., Abdela, J., Adhikari, T.B., Aghayan, S.A., Agrawal, S., Ahmadi, A., Aichour, A.N., Aichour, I., Aichour, M.T.E., Al-Eyadhy, A., Al-Raddadi, R.M., Alahdab, F., Alene, K.A., Aljunid, S.M., Alvis-Guzman, N., Anber, N.H., Anjomshoa, M., Antonio, C.A.T., Aremu, O., Atalay, H.T., Atique, S., Attia, E.F., Avokpaho, E.F.G., Awasthi, A., Babazadeh, A., Badali, H., Badawi, A., Banoub, J.A.M., Barac, A., Bassat, Q., Bedi, N., Belachew, A.B., Bennett, D.A., Bhattacharyya, K., Bhutta, Z.A., Bijani, A., Carvalho, F., Castañeda-Orjuela, C.A., Christopher, D.J., Dandona, L., Dandona, R., Dang, A.K., Daryani, A., Degefa, M.G., Demeke, F.M., Dhimal, M., Djalalinia, S., Doku, D.T., Dubey, M., Dubljanin, E., Duken, E.E., Edessa, D., El Sayed Zaki, M., Fakhim, H., Fernandes, E., Fischer, F., Flor, L.S., Foreman, K.J., Gebremichael, T.G., Geremew, D., Ghadiri, K., Goulart, A.C., Guo, J., Ha, G.H., Hailu, G.B., Haj-Mirzaian, A., Haj-Mirzaian, A., Hamidi, S., Hassen, H.Y., Hoang, C.L., Horita, N., Hostiuc, M., Irvani, S.S.N., Jha, R.P., Jonas, J.B., Kahsay, A., Karch, A., Kasaeian, A., Kassa, T.D., Kefale, A.T., Khader, Y.S., Khan, E.A., Khan, G., Khan, M.N., Khang, Y.H., Khoja, A.T., Khubchandani, J., Kimokoti, R.W., Kisa, A., Knibbs, L.D., Kochhar, S., Kosen, S., Koul, P.A., Koyanagi, A., Kuate Defo, B., 2019. Mortality, morbidity, and hospitalisations due to influenza lower respiratory tract infections, 2017: An analysis for the Global Burden of Disease Study 2017. The Lancet Respiratory Medicine, 7, pp.69-89.

Trucchi, C., Paganino, C., Orsi, A., Amicizia, D., Tisa, V., Piazza, M.F., Gallo, D., Simonetti, S., Buonopane, B., Icardi, G. and Ansaldi, F., 2019. Hospital and economic burden of influenza-like illness and lower respiratory tract infection in adults ≥50years-old. BMC Health Services Research, 19, p.585.

Woodhead, M., Blasi, F., Ewig, S., Garau, J., Huchon, G., Ieven, M., Ortqvist,A., Schaberg, T., Torres, A., Van Der Heijden, G., Read, R. and Verheij, T.J.M., 2011. Guidelines for the management of adult lower respiratory tract infections summary. Clinical Microbiology and Infection, 17, pp.1-24.

Yan, T., Li, Y., Sun, Y., Wang, H., Wang, J., Wang, W., Liu, Y., Wu, X. and Wang, S., 2018. Hospital-acquired lower respiratory tract infections among high risk hospitalized patients in a tertiary care teaching hospital in China: An economic burden analysis. Journal of Infection and Public Health, 11, pp.507-513.

Yin, C.C., Huah, L.W., Lin, J.T.P., Goh, A., Ling, H. and Moh, C.O., 2003. Lower respiratory tract infection in hospitalized children. Respirology, 8, pp.83-89.

ARO Journal: Volume 8, No. 2 (2020)
Published
2020-12-07
How to Cite
Chawsheen, M. A., Al-Naqshbandi, A. A. and Abdulqader, H. H. (2020) “Bacterial Profile and Antimicrobial Susceptibility of Isolates Recovered from Lower Respiratory Tract Infection for Patients in Rizgary Hospital, Erbil”, ARO-THE SCIENTIFIC JOURNAL OF KOYA UNIVERSITY, 8(2), pp. 64-70. doi: 10.14500/aro.10724.
Issue
Vol. 8 No. 2 (2020): Issue Fifteen
Section
Articles

Copyright (c) 2020 Mahmoud A. Chawsheen, Ahmed A. Al-Naqshbandi, Haval H. Abdulqader

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Authors who choose to publish their work with Aro agree to the following terms:

  • Authors retain the copyright to their work and grant the journal the right of first publication. The work is simultaneously licensed under a Creative Commons Attribution License [CC BY-NC-SA 4.0]. This license allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

  • Authors have the freedom to enter into separate agreements for the non-exclusive distribution of the journal's published version of the work. This includes options such as posting it to an institutional repository or publishing it in a book, as long as proper acknowledgement is given to its initial publication in this journal.

  • Authors are encouraged to share and post their work online, including in institutional repositories or on their personal websites, both prior to and during the submission process. This practice can lead to productive exchanges and increase the visibility and citation of the published work.

By agreeing to these terms, authors acknowledge the importance of open access and the benefits it brings to the scholarly community.

Crossref
Scopus
Google Scholar
Europe PMC